Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Sanofi S.A. | 4 | 0 | 1 | 0 | €101.34 | €109.00 | 7.559% |
| Abbott Laboratories | 21 | 0 | 4 | 0 | €101.78 | €116.48 | 14.443% |
| Merck & Co. Inc. | 32 | 1 | 4 | 0 | €106.20 | €125.78 | 18.436% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €125.00 | €130.00 | 4.000% |
| Neurocrine Bioscience | 45 | 0 | 10 | 0 | €114.15 | €150.00 | 31.406% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €124.00 | €150.00 | 20.968% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €157.80 | €165.00 | 4.563% |
| Merck KGaA | 5 | 1 | 2 | 0 | €174.65 | €172.00 | -1.517% |
| Repligen Corp. | 15 | 0 | 4 | 0 | €130.50 | €178.01 | 36.408% |
| AbbVie Inc. | 34 | 0 | 3 | 0 | €177.00 | €180.90 | 2.205% |
| Jazz Pharmaceuticals plc | 30 | 0 | 6 | 0 | €104.70 | €183.41 | 75.181% |
| Krystal Biotech | 20 | 0 | 4 | 0 | €184.55 | €186.59 | 1.105% |
| Johnson & Johnson | 40 | 1 | 4 | 0 | €148.38 | €187.62 | 26.442% |
| Novo Nordisk A/S | 6 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Zoetis Inc. A | 25 | 1 | 4 | 0 | €166.34 | €198.11 | 19.101% |
| BeiGene Ltd ADR | 10 | 1 | 2 | 0 | €179.00 | €238.56 | 33.276% |
| Alnylam Pharmace. | 45 | 0 | 7 | 0 | €259.00 | €275.25 | 6.274% |
| Amgen Inc. | 28 | 0 | 3 | 0 | €300.55 | €304.82 | 1.420% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €225.80 | €315.00 | 39.504% |
| Icon plc | 24 | 0 | 0 | 0 | €288.10 | €326.21 | 13.228% |